Search results
Results from the WOW.Com Content Network
Key takeaways. Breast cancer survivors can still access life insurance, especially after remission, though coverage terms may vary based on individual health history and the time since treatment.
Key takeaways. Life insurance is available for cancer patients, though options and rates vary widely. The stage, type and history of cancer all impact life insurance eligibility and cost.
Dan Amos has spent his 34 years as CEO of Aflac selling insurance against illness and death, but there are some endings that all the insurance in the world can’t prevent. ... where cancer rates ...
In 2009, Aflac acquired Continental American Insurance Company for $100 million, [5] enabling them to sell supplemental insurance on both the individual and group platforms. [6] As of June 30, 2012 [update] , it was represented by approximately 19,300 sales agencies in Japan and 76,900 licensed sales associates in the U.S. [ 7 ]
Cancer insurance is a type of supplemental health insurance that is meant to manage the risks associated with the cancer disease and its numerous manifestations. Cancer insurance is a relatively new trend within the insurance industry. It is meant to mitigate the costs of cancer treatment and provide policyholders with a degree of financial ...
Progression-free survival (PFS) is "the length of time during and after the treatment of a disease, such as cancer, that a patient lives with the disease but it does not get worse". [1] In oncology, PFS usually refers to situations in which a tumor is present, as demonstrated by laboratory testing, radiologic testing, or clinically. Similarly ...
Health insurance company interference is rising, an NBC News investigation found. Doctors say the stakes are highest in cancer care, where delays can be the difference between life and death.
The American Cancer Society reports 5-year relative survival rates of over 70% for women with stage 0-III breast cancer with a 5-year relative survival rate close to 100% for women with stage 0 or stage I breast cancer. The 5-year relative survival rate drops to 22% for women with stage IV breast cancer. [3]